An investor asked a question on the investor interaction platform: Dear Secretary Zhang: Hello! Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) the company has always been based on people-oriented, strengthening the country with science and technology, and making profits with R & D and innovation! How many countries are your medical devices and small molecule drugs now exported? Is there an increase in sales? thank you!
Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) (300832. SZ) said on the investor interaction platform on December 25 that it is not involved in drug R & D and production business at present. The company is mainly engaged in the R & D, production, sales and service of in vitro diagnostic products; After years of market layout and development, by the end of June 2021, the company's products have been exported to 146 countries and regions such as Asia, Europe, America, Africa and Oceania. With the orderly promotion of snibe brand construction, sales channel optimization, academic promotion and product registration, the company's overseas revenue will reach 823 million yuan in 2020. In the first half of 2021, the company's overseas reagent revenue (excluding covid-19 luminous reagent) increased by 123.73% year-on-year.
(Daily Economic News)
